NanoViricides
NNVC
40 hedge funds and large institutions have $8.92M invested in NanoViricides in 2014 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 3 closing their positions.
467% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 3
142% more call options, than puts
Call options by funds: $783K | Put options by funds: $323K
87% more capital invested
Capital invested by funds: $4.77M → $8.92M (+$4.15M)
50% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 6
48% more funds holding
Funds holding: 27 → 40 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.95M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$687K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$683K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$611K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$499K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$528K |
| 2 |
WAM
Weatherly Asset Management
Del Mar,
California
|
-$205K |
| 3 |
Morgan Stanley
New York
|
-$43.2K |
| 4 |
California Public Employees Retirement System
Sacramento,
California
|
-$26K |
| 5 |
Bank of New York Mellon
New York
|
-$24.4K |
NNVC Hedge Fund Activity: Q1 2014 in Review
40 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q1 2014, worth a combined $8.92M — up 87% from $4.77M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new NNVC positions and 3 closed out — a net gain of 14 holders — while 9 added to existing stakes and 6 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.95M. The largest seller was Bank of America, cutting an estimated $528K.
- 40 institutional investors held NanoViricides (NNVC) as of Q1 2014, up from 27 in Q4 2013.
- Funds reported $8.92M of NanoViricides stock for Q1 2014, up 87% quarter-over-quarter.
- 17 funds opened new NanoViricides positions in Q1 2014 and 3 closed out, a net change of +14 holders.
- The largest NanoViricides buyer in Q1 2014 was Vanguard Group, an estimated $2.95M added.
- The largest NanoViricides seller in Q1 2014 was Bank of America, an estimated $528K sold.
Based on aggregated 13F filings for Q1 2014.